This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Mar-Apr;16(2):162-6.

doi: 10.4158/EP10038.ED.

W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?

Christos S Mantzoros

PMID: 20350904
DOI: 10.4158/EP10038.ED

Editorial

W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?

Christos S Mantzoros. Endocr Pract. 2010 Mar-Apr.

. 2010 Mar-Apr;16(2):162-6.

doi: 10.4158/EP10038.ED.

Author

Christos S Mantzoros

PMID: 20350904
DOI: 10.4158/EP10038.ED

No abstract available

PubMed Disclaimer

Comment on

Rationale for leptin-replacement therapy for severe lipodystrophy.
Oral EA, Chan JL. Oral EA, et al. Endocr Pract. 2010 Mar-Apr;16(2):324-33. doi: 10.4158/EP09155.RA. Endocr Pract. 2010. PMID: 20061299 Review.
Clinical classification and treatment of congenital and acquired lipodystrophy.
Chan JL, Oral EA. Chan JL, et al. Endocr Pract. 2010 Mar-Apr;16(2):310-23. doi: 10.4158/EP09154.RA. Endocr Pract. 2010. PMID: 20061300 Review.

Similar articles

Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
Meehan CA, Cochran E, Kassai A, Brown RJ, Gorden P. Meehan CA, et al. Expert Rev Clin Pharmacol. 2016;9(1):59-68. doi: 10.1586/17512433.2016.1096772. Epub 2015 Oct 14. Expert Rev Clin Pharmacol. 2016. PMID: 26465174 Free PMC article. Review.
First metreleptin treatment for generalized lipodystrophy in Turkey.
Simsir IY, Yurekli BS, Saygili F, Altay C, Akinci B. Simsir IY, et al. Diabetes Obes Metab. 2017 Feb;19(2):299-301. doi: 10.1111/dom.12796. Epub 2016 Nov 9. Diabetes Obes Metab. 2017. PMID: 27717125 No abstract available.
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.
Tchang BG, Shukla AP, Aronne LJ. Tchang BG, et al. Expert Opin Biol Ther. 2015 Jul;15(7):1061-75. doi: 10.1517/14712598.2015.1052789. Expert Opin Biol Ther. 2015. PMID: 26063386 Review.
Rationale for leptin-replacement therapy for severe lipodystrophy.
Oral EA, Chan JL. Oral EA, et al. Endocr Pract. 2010 Mar-Apr;16(2):324-33. doi: 10.4158/EP09155.RA. Endocr Pract. 2010. PMID: 20061299 Review.
Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
Diker-Cohen T, Cochran E, Gorden P, Brown RJ. Diker-Cohen T, et al. J Clin Endocrinol Metab. 2015 May;100(5):1802-10. doi: 10.1210/jc.2014-4491. Epub 2015 Mar 3. J Clin Endocrinol Metab. 2015. PMID: 25734254 Free PMC article. Clinical Trial.

See all similar articles

Cited by

Leptin as a modulator of neuroendocrine function in humans.
Khan SM, Hamnvik OP, Brinkoetter M, Mantzoros CS. Khan SM, et al. Yonsei Med J. 2012 Jul 1;53(4):671-9. doi: 10.3349/ymj.2012.53.4.671. Yonsei Med J. 2012. PMID: 22665330 Free PMC article. Review.
Metreleptin: first global approval.
Chou K, Perry CM. Chou K, et al. Drugs. 2013 Jun;73(9):989-97. doi: 10.1007/s40265-013-0074-7. Drugs. 2013. PMID: 23740412 Review.
Leptin in relation to the lipodystrophy-associated metabolic syndrome.
Mantzoros CS. Mantzoros CS. Diabetes Metab J. 2012 Jun;36(3):181-9. doi: 10.4093/dmj.2012.36.3.181. Epub 2012 Jun 14. Diabetes Metab J. 2012. PMID: 22737657 Free PMC article.
Leptin in human physiology and pathophysiology.
Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, Hamnvik OP, Koniaris A. Mantzoros CS, et al. Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E567-84. doi: 10.1152/ajpendo.00315.2011. Epub 2011 Jul 26. Am J Physiol Endocrinol Metab. 2011. PMID: 21791620 Free PMC article. Review.
Leptin in human physiology and therapeutics.
Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Dardeno TA, et al. Front Neuroendocrinol. 2010 Jul;31(3):377-93. doi: 10.1016/j.yfrne.2010.06.002. Epub 2010 Jun 17. Front Neuroendocrinol. 2010. PMID: 20600241 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information